시장보고서
상품코드
1454122

심장질환 및 신경용 IVD 시장 : 제품 유형별, 기술별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

IVD In Cardiology And Neurology Market, By Product Type, By Technology, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 300 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

심장병 및 신경용 IVD 시장 규모는 2023년 159억 6,500만 달러로 평가되었고, 2024-2032년 연평균 9.5% 성장할 것으로 예상됩니다.

심장질환 및 신경용 IVD 시장 - 시장 역학

심혈관 질환의 유병률 증가는 시장 수요를 촉진합니다.

심혈관 질환의 유병률 증가는 예측 기간 동안 심장 및 신경 IVD 시장을 촉진할 것으로 예상됩니다. 예를 들어, 국립보건원(National Institutes of Health)이 발표한 자료에 따르면, 인도에서 CVD로 인한 사망자 수는 1990년 226만 명에서 2020년에는 477만 명으로 증가할 것으로 예상됩니다. 지난 수십년동안 인도의 관상동맥 심장병 유병률은 농촌 지역에서는 1.6%에서 7.4%, 대도시 지역에서는 1%에서 13.2%까지 다양한 수치가 추정됩니다. 따라서 앞서 언급한 통계가 시장 성장의 원동력이 되고 있습니다.

심장 및 신경 IVD 시장 - 주요 인사이트

당사의 리서치 애널리스트 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 9.5%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

제품 유형별로는 시약 및 소모품 부문이 예측 기간 동안 큰 시장 점유율을 차지할 것으로 예상됩니다.

기술 세분화를 기준으로 2023년에는 면역 분석 세분화가 가장 큰 시장 점유율을 차지했습니다.

최종 용도 세분화에 따라 병원 부문이 예측 기간 동안 시장을 주도할 것으로 예상됩니다.

지역별로는 북미가 2023년 매출 1위

심장병 및 신경용 IVD 시장 - 세분화 분석 :

심장 및 신경용 IVD 세계 시장은 제품 유형, 기술, 최종 용도 및 지역에 따라 세분화됩니다.

제품 유형에 따라 시장은 기기, 시약 및 소모품, 소프트웨어 및 서비스로 분류됩니다. 시약 및 소모품 부문은 예측 기간 동안 큰 시장 점유율을 차지할 것으로 예상됩니다. 면역화학 실험에는 형광 태그, 세척 완충액, 특정 항체, 단백질 바이오마커를 포함한 시약이 사용되며, PCR 검사에는 염화마그네슘, dNTP 믹스, 프라이머 믹스 등 다양한 물질이 사용됩니다. 프라이머 세트와 형광 표지 뉴클레오티드는 분자진단법에서 가장 일반적으로 사용되는 주요 시약입니다. Abbott, Roche Diagnostics, Illumina가 주요 시약 공급업체입니다. 주요 업체들이 연구개발을 통해 혁신적인 바이오마커 키트를 개발하면서 이 분야가 성장하고 있습니다. 또한, 새로운 시약의 출시와 상용화가 시장 확대를 촉진할 것으로 예상됩니다.

기술에 따라 분자진단, 면역 분석, 혈액학, 기타로 나뉘며, 2023년에는 면역 분석이 가장 큰 시장 점유율을 차지할 것으로 예상되며, 예측 기간 동안에도 동일한 패턴이 지속될 것으로 예상됩니다. 면역학에서는 면역 체계의 다양한 역할을 이해하기 위해 분자 경로를 연구하고 있습니다. 주로 항원과 항체의 상호 작용 및 작용 메커니즘의 평가로 구성됩니다. 기업들은 면역 분석의 개발 및 판매에 주력하고 있습니다.

최종 용도에 따라 업계는 임상 실험실, 병원 및 기타로 나뉩니다. 병원 분야는 의사가 치료를 진행하기 위해 진단 해석이 필요하기 때문에 예측 기간 동안 시장을 주도할 것으로 예상되며, 이 분야의 발전이 기대되는 분야입니다.

심장병 및 신경계 IVD 시장 - 지리적 통찰력

지리적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역들은 사업 진출 국가에 따라 더 세분화되어 있습니다. 북미는 심혈관 및 신경 질환의 유병률 증가, 유익한 정부 프로그램 확대 등 여러 변수로 인해 예측 기간 동안 심장 및 신경 IVD 시장을 주도할 것으로 예상됩니다. 또한, 혁신적인 바이오마커 연구개발에 대한 제품 출시와 자금 조달 증가도 시장 성장에 박차를 가할 것으로 예상됩니다.

심장질환 및 신경용 IVD 시장 - 경쟁 상황:

시장에서 활동하는 주요 기업으로는 Quest Diagnostics Incorporated, BD, Sysmex Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc. 등이 있습니다. 시장 진출기업은 새로운 시장에 접근하기 위해 신제품 개발, 자금 조달 및 투자, 인수합병(M&A), 기타 전략적 제휴 등 다양한 전략적 이니셔티브를 지속적으로 추구하고 있습니다.

목차

제1장 심장질환 및 신경용 IVD 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 심장질환 및 신경용 IVD 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 시장 동향

제4장 심장질환 및 신경용 IVD 업계 조사

  • PEST 분석
  • Porter의 Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 심장질환 및 신경용 IVD 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 심장질환 및 신경용 IVD 시장 구도

  • 심장질환 및 신경용 IVD 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 심장질환 및 신경용 IVD 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 기기
    • 시약 및 소모품
    • 소프트웨어 및 서비스

제8장 심장질환 및 신경용 IVD 시장 - 기술별

  • 개요
    • 기술별 부문 점유율 분석
    • 분자진단
    • 면역분석
    • 혈액학
    • 기타

제9장 심장질환 및 신경용 IVD 시장 - 최종 용도별

  • 개요
    • 최종 용도별 부문 점유율 분석
    • 임상실험실
    • 병원
    • 기타

제10장 심장질환 및 신경용 IVD 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 심장질환 및 신경용 IVD 업계

  • 경쟁 대시보드
  • 기업 개요
    • Quest Diagnostics Incorporated
    • BD
    • Sysmex Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Beckman Coulter, Inc.
    • Cardiol Therapeutics

제12장 애널리스트의 전방위 전망

LSH 24.04.30

REPORT HIGHLIGHT

IVD In Cardiology And Neurology Market size was valued at USD 15,965 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The term "in vitro diagnostics" (IVD) describes the use of instruments, techniques, and reagents designed for the analysis of specimens-such as blood, urine, tissue, and other bodily fluids-outside of the body to aid in the diagnosis of illnesses, ailments, or infections. These laboratory-based tests are intended to give information on a patient's health state, supporting the identification of illnesses, selection of appropriate courses of treatment, and ongoing monitoring of those illnesses.

IVD In Cardiology And Neurology Market- Market Dynamics

Growing prevalence of cardiovascular disease to propel market demand

The growing prevalence of cardiovascular disease is expected to propel the IVD In Cardiology And Neurology market over the projected period. For instance, according to the data published by National Institutes of Health, it is anticipated that the number of fatalities in India from CVD would increase from 2.26 million in 1990 to 4.77 million in 2020. Over the past few decades, estimates of the prevalence of coronary heart disease in India have varied, with figures ranging from 1.6% to 7.4% in rural areas and from 1% to 13.2% in metropolitan areas. Thus, the aforementioned stats drive the market growth.

IVD In Cardiology And Neurology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, the Reagents & Consumables segment is expected to capture a significant market share during the forecast period

Based on the technology segmentation, the Immunoassays segment held the largest market share in 2023

Based on end-use segmentation, the hospitals segment is expected to lead the market over the projected period

Based on region, North America was the leading revenue generator in 2023

IVD In Cardiology And Neurology Market- Segmentation Analysis:

The Global IVD In Cardiology And Neurology Market is segmented based on Product Type, Technology, End-use, and Region.

Based on the product type, the market is categorized into Instruments, Reagents & Consumables and Software and Services. The Reagents & Consumables segment is expected to capture a significant market share during the forecast period. In immunochemistry experiments, reagents including fluorescent tags, washing buffers, particular antibodies, and protein biomarkers are utilized. PCR tests are carried out using a variety of substances, including magnesium chloride, dNTP mix, and primer mix. Primer sets and fluorescent-labeled nucleotides are the main and most commonly utilized reagents in molecular diagnostic procedures. Abbott, Roche Diagnostics, and Illumina, Inc. are the main suppliers of reagents. The development of innovative biomarker kits by key manufacturers through considerable R&D activities is credited with the segment's rise. Additionally, it is anticipated that the launch and commercialization of novel reagents would propel market expansion.

Based on the technology, the market is divided into Molecular Diagnostics, Immunoassays, Hematology and Others. The Immunoassays held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. Molecular pathways are studied in immunology to comprehend the diverse roles that the immune system plays. It primarily consists of an evaluation of the interactions between antigens and antibodies as well as their mechanisms of action. Businesses are concentrating on the creation and marketing of immunoassays.

Based on the end-use, the industry is divided into Clinical Laboratories, Hospitals and Others. The hospitals segment is expected to lead the market over the projected period due to the fact that physicians need diagnostic interpretation to proceed with therapy, the segment is expected to develop.

IVD In Cardiology And Neurology Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the IVD In Cardiology And Neurology market during the forecast period due to a number of variables, including the growing prevalence of cardiovascular and neurological diseases and the expansion of beneficial government programs. Growth in the market is also anticipated to be fueled by more product releases and financing for the R&D of innovative biomarkers.

IVD In Cardiology And Neurology Market- Competitive Landscape:

The key players operating in the market are Quest Diagnostics Incorporated, BD, Sysmex Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc. and Cardiol Therapeutics. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In July 2023, a collaboration between Fujirebio and Beckman Coulter, Inc. aims to improve patient access to blood-based Alzheimer disease testing. The collaboration intends to pool the business's immunoassay capabilities to provide support.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Quest Diagnostics Incorporated

BD

Sysmex Corporation

Siemens Healthineers AG

Thermo Fisher Scientific Inc.

Abbott

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

Beckman Coulter, Inc.

Cardiol Therapeutics

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Reagents & Consumables
  • Software and Services

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassays
  • Hematology
  • Others

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Laboratories
  • Hospitals
  • Others

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.IVD IN CARDIOLOGY AND NEUROLOGY Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Product Type
    • 2.1.2.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Technology
    • 2.1.3.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by End-use
    • 2.1.4.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Country
    • 2.1.5.IVD IN CARDIOLOGY AND NEUROLOGY Market Snippet by Region
  • 2.2.Competitive Insights

3.IVD IN CARDIOLOGY AND NEUROLOGY Key Market Trends

  • 3.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.IVD IN CARDIOLOGY AND NEUROLOGY Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.IVD IN CARDIOLOGY AND NEUROLOGY Market Opportunities
  • 3.4.IVD IN CARDIOLOGY AND NEUROLOGY Market Future Trends

4.IVD IN CARDIOLOGY AND NEUROLOGY Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.IVD IN CARDIOLOGY AND NEUROLOGY Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.IVD IN CARDIOLOGY AND NEUROLOGY Market Landscape

  • 6.1.IVD IN CARDIOLOGY AND NEUROLOGY Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.IVD IN CARDIOLOGY AND NEUROLOGY Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Instruments
    • 7.1.3.Reagents & Consumables
    • 7.1.4.Software and Services

8.IVD IN CARDIOLOGY AND NEUROLOGY Market - By Technology

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2.Molecular Diagnostics
    • 8.1.3.Immunoassays
    • 8.1.4.Hematology
    • 8.1.5.Others

9.IVD IN CARDIOLOGY AND NEUROLOGY Market - By End-use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 9.1.2.Clinical Laboratories
    • 9.1.3.Hospitals
    • 9.1.4.Others

10.IVD IN CARDIOLOGY AND NEUROLOGY Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.IVD IN CARDIOLOGY AND NEUROLOGY Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- IVD IN CARDIOLOGY AND NEUROLOGY Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Quest Diagnostics Incorporated
    • 11.2.2.BD
    • 11.2.3.Sysmex Corporation
    • 11.2.4.Siemens Healthineers AG
    • 11.2.5.Thermo Fisher Scientific Inc.
    • 11.2.6.Abbott
    • 11.2.7.F. Hoffmann-La Roche Ltd.
    • 11.2.8.Bio-Rad Laboratories, Inc.
    • 11.2.9.Beckman Coulter, Inc.
    • 11.2.10.Cardiol Therapeutics

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제